These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74. Endotoxin (Salmonella abortus equi) in cancer patients. Clinical and immunological findings. Engelhardt R; Otto F; Mackensen A; Mertelsmann R; Galanos C Prog Clin Biol Res; 1995; 392():253-61. PubMed ID: 8524930 [TBL] [Abstract][Full Text] [Related]
75. Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results. Palmer CD; Rappaport AR; Davis MJ; Hart MG; Scallan CD; Hong SJ; Gitlin L; Kraemer LD; Kounlavouth S; Yang A; Smith L; Schenk D; Skoberne M; Taquechel K; Marrali M; Jaroslavsky JR; Nganje CN; Maloney E; Zhou R; Navarro-Gomez D; Greene AC; Grotenbreg G; Greer R; Blair W; Cao MD; Chan S; Bae K; Spira AI; Roychowdhury S; Carbone DP; Henick BS; Drake CG; Solomon BJ; Ahn DH; Mahipal A; Maron SB; Johnson B; Rousseau R; Yelensky R; Liao CY; Catenacci DVT; Allen A; Ferguson AR; Jooss K Nat Med; 2022 Aug; 28(8):1619-1629. PubMed ID: 35970920 [TBL] [Abstract][Full Text] [Related]
76. Toxicology and biodistribution of AdAPT-001, a replication-competent type 5 adenovirus with a trap for the immunosuppressive cytokine, TGF-beta. Larson C; Oronsky B; Abrouk NE; Oronsky A; Reid TR Am J Cancer Res; 2021; 11(10):5184-5189. PubMed ID: 34765319 [TBL] [Abstract][Full Text] [Related]
77. Patient experience of medication administration and development of a Patient Experience and Preference Questionnaire (PEPQ) for patients with advanced or metastatic cancer. Skalicky A; Bennett B; Raimbourg J; Lonardi S; Correll J; Lugowska I; Dixon M; Sargalo N; Martin ML Front Pharmacol; 2024; 15():1310546. PubMed ID: 38601466 [No Abstract] [Full Text] [Related]
78. Commentary: Prehabilitation for increasing ventilatory efficiency before lung resection: Amazing concept, but we're not there yet! Ben Ali W; Liberman M; Perrault LP J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2513-2514. PubMed ID: 30954302 [No Abstract] [Full Text] [Related]
79. Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma. Lang FF; Conrad C; Gomez-Manzano C; Yung WKA; Sawaya R; Weinberg JS; Prabhu SS; Rao G; Fuller GN; Aldape KD; Gumin J; Vence LM; Wistuba I; Rodriguez-Canales J; Villalobos PA; Dirven CMF; Tejada S; Valle RD; Alonso MM; Ewald B; Peterkin JJ; Tufaro F; Fueyo J J Clin Oncol; 2018 May; 36(14):1419-1427. PubMed ID: 29432077 [TBL] [Abstract][Full Text] [Related]
80. Phase I Study of Oncolytic Vaccinia Virus GL-ONC1 in Patients with Peritoneal Carcinomatosis. Lauer UM; Schell M; Beil J; Berchtold S; Koppenhöfer U; Glatzle J; Königsrainer A; Möhle R; Nann D; Fend F; Pfannenberg C; Bitzer M; Malek NP Clin Cancer Res; 2018 Sep; 24(18):4388-4398. PubMed ID: 29773661 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]